Extracellular Vesicles: Multimodal Tools for Diagnosis, Prognosis, and Therapy in Respiratory Diseases
Expert Reviews in Molecular Medicine · 2025
DOI: 10.1017/erm.2025.10025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, 2025. Verfasst von Miquéias Lopes-Pacheco. Beteiligte Einrichtung: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Respiratory Tract Diseases, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Respiratory diseases are increasing global health burden with persistently high morbidity and mortality. Extracellular vesicles (EVs), which are virtually released by all cell types and carry a variety of molecules like miRNAs, have emerged as crucial mediators of intercellular communication. They play a key role in maintaining lung homeostasis and are involved in the pathogenesis of various respiratory conditions. Furthermore, mesenchymal stromal cell-derived EVs (MSC-EVs) have shown significant therapeutic potential due to their anti-inflammatory, antimicrobial, and reparative properties.
Methods
This narrative review critically assesses the current body of literature on the roles of EVs in respiratory diseases. We examine evidence from pre-clinical and clinical studies that investigate EVs as biomarkers and therapeutics for conditions including asthma, bronchopulmonary dysplasia (BPD), chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), idiopathic pulmonary fibrosis (IPF), lung cancer, and pulmonary arterial hypertension (PAH).
Results
EVs reflect the physiological or pathological state of their parental cells, making them promising multimodal biomarkers for the early diagnosis and monitoring of disease progression. Additionally, MSC-EVs function as effective, cell-free therapeutic agents. In a variety of disease models, they demonstrate efficacy by modulating immune responses, enhancing alveolar fluid clearance, and restoring epithelial and endothelial barrier integrity, leading to improved survival and outcomes.
Conclusions
EVs hold a dual and transformative potential in respiratory medicine. They may serve as valuable diagnostic and prognostic tools, and their application as cell-free therapeutics represents a novel and promising strategy for treating a wide spectrum of debilitating respiratory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
- Center for Cystic Fibrosis and Airways Disease Research, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, USA.
ORCID-Profile: Miquéias Lopes-Pacheco
Zitieren
APA
Lopes-Pacheco, M. (2025). Extracellular Vesicles: Multimodal Tools for Diagnosis, Prognosis, and Therapy in Respiratory Diseases. Expert Reviews in Molecular Medicine. https://doi.org/10.1017/erm.2025.10025
Vancouver
Lopes-Pacheco M. Extracellular Vesicles: Multimodal Tools for Diagnosis, Prognosis, and Therapy in Respiratory Diseases. Expert Reviews in Molecular Medicine. 2025. doi:10.1017/erm.2025.10025
BibTeX
@article{LopesPacheco2025,
author = {Lopes-Pacheco, Miquéias},
title = {Extracellular Vesicles: Multimodal Tools for Diagnosis, Prognosis, and Therapy in Respiratory Diseases},
journal = {Expert Reviews in Molecular Medicine},
year = {2025},
doi = {10.1017/erm.2025.10025}
}
EUVIMED